Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
Psicol. ciênc. prof ; 43: e254081, 2023. graf
Article in Portuguese | LILACS, INDEXPSI | ID: biblio-1440799

ABSTRACT

Este artigo pretende conhecer como a rede de cuidados em saúde tem se operacionalizado a partir da percepção de familiares de crianças com demanda de cuidado em saúde mental (SM). Foram realizados dois grupos focais, um com familiares da Atenção Básica (AB) e outro com familiares do Centro de Atenção Psicossocial Infantojuvenil (CAPSij), totalizando 15 participantes. Seguiu-se com a análise lexical do tipo classificação hierárquica descendente, com o auxílio do software R Interface, a fim de análises multidimensionais de textos e questionários (IRaMuTeQ), resultando em cinco classes: A Pílula Mágica; Forças e Fraquezas dos serviços; Procurando por ajuda; Aceitando o diagnóstico da criança e Onde procurei ajuda. Os resultados apontam para dificuldades presentes na AB em identificar e manejar situações de Saúde Mental Infantojuvenil (SMIJ), por meio de uma lógica ainda medicalizante. Ressalta-se que a escola é apresentada como lugar de destaque na produção da demanda por cuidado e a família ainda é pouco convocada à construção das ações. Conclui-se, então, que avanços ainda são necessários para operacionalização de um cuidado pautado nas diretrizes da política de SMIJ.(AU)


This article aims to know how the healthcare network has been operationalized from the perception of family members of children with demand for mental health care (MH). Two focus groups were held, one with family members from Primary Care (PC) and the other with family members from the Child Psychosocial Care Center (CAPSij), totaling 15 participants. A lexical analysis of the descending hierarchical classification type was performed with the help of the software R Interface for multidimensional analyzes of texts and questionnaires (IRAMUTEQ), resulting in five classes: The Magic Pill; Strengths and Weaknesses of services; Looking for help; Accepting the child's diagnosis; and Where did I look for help. The results point to difficulties present in PC in identifying and managing situations of mental health in children and adolescents (MHCA), with a medicalization logic. Note that the school is presented as a prominent place in producing the demand for care, and the family is still not very much involved in the actions. It is, thus, concluded that advances are still needed for operationalization of care guided by MHCA policy guidelines.(AU)


Este artículo tuvo por objetivo conocer cómo opera una red asistencial a partir de la percepción de familiares de niños con demanda de atención en salud mental (SM). Se realizaron dos grupos focales, uno con familiares de Atención Primaria (AP) y otro con familiares del Centro de Atención Psicosocial Infantojuvenil (CAPSij), totalizando 15 participantes. Se realizó análisis léxico del tipo clasificación jerárquica descendente con la ayuda del software Interface de R pour les Analyses Multidimensionnelles de Textes et de Questionnaires (IRAMUTEQ), lo que resultó en cinco clases: "La píldora mágica"; "Fortalezas y debilidades de los servicios"; "En busca de ayuda"; "Aceptar el diagnóstico del niño" y "¿Dónde busqué ayuda?". Los resultados apuntan las dificultades presentes en AP para identificar y manejar situaciones de salud mental infantojuvenil (SMIJ) mediante una lógica aún medicalizante. La escuela tiene un lugar destacado en la producción de la demanda de cuidados y la familia aún no está muy involucrada en la construcción de acciones. Se concluye que se necesitan avances para ofertar una atención guiada por lineamientos de la política del SMIJ.(AU)


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adult , Middle Aged , Young Adult , Child , Adolescent , Intersectoral Collaboration , Mental Health Assistance , Health Policy , Anxiety Disorders , Parents , Patient Escort Service , Pediatrics , Play and Playthings , Play Therapy , Prejudice , Professional-Family Relations , Professional-Patient Relations , Proprioception , Psychoanalysis , Psychology , Psychomotor Disorders , Psychotherapy , Psychotic Disorders , Referral and Consultation , Attention Deficit Disorder with Hyperactivity , Self Care , Autistic Disorder , Social Alienation , Social Environment , Social Isolation , Social Support , Socialization , Pathological Conditions, Signs and Symptoms , Therapeutics , Violence , Mainstreaming, Education , Shyness , Neurosciences , Adaptation, Psychological , Patient Acceptance of Health Care , Health Centers , Cognitive Behavioral Therapy , Comorbidity , Child Advocacy , Child Behavior Disorders , Child Care , Child Development , Developmental Disabilities , Child Language , Occupational Therapy , Cognition , Communication Disorders , Neurobehavioral Manifestations , Stereotypic Movement Disorder , Behavioral Disciplines and Activities , Disabled Children , Affect , Crying , Aggression , Dermatitis, Contact , Diagnosis , Dissociative Disorders , Dyslexia , Echolalia , Education , Education of Intellectually Disabled , Education, Special , Emotions , Family Conflict , Speech, Language and Hearing Sciences , Medication Adherence , Apathy , Acceptance and Commitment Therapy , Emotional Adjustment , Literacy , Neurodevelopmental Disorders , Autism Spectrum Disorder , Orientation, Spatial , Applied Behavior Analysis , Cognitive Remediation , Emotion-Focused Therapy , Pediatricians , Data Analysis , Sadness , Psychological Distress , Social Interaction , Health Services Accessibility , Human Rights , Hyperkinesis , Intelligence , Interpersonal Relations , Anger , Language Disorders , Learning , Learning Disabilities , Loneliness , Malpractice , Mental Disorders , Intellectual Disability , Nervous System Diseases , Obsessive-Compulsive Disorder
2.
Nutr Neurosci ; 25(9): 1995-2007, 2022 Sep.
Article in English | MEDLINE | ID: mdl-33871323

ABSTRACT

METHODS: We searched seven databases and found 13 eligible controlled trials that use omega-3 supplementation in children and adolescents with ASD.Data extraction: We collected details on study design, intervention time, supplement dosage, and the autism assessment scale. Meta-analyses and subgroup analysis were conducted according to the autism symptoms. RESULTS: Omega-3 and omega-6 supplementation improved ASD symptoms according to the Aberrant Behavior Checklist (standard mean difference - SMD = -0.13; CI 95% = -0.34, -0.02). However, using subgroup analysis, we observed no efficacy in terms of improvements in hyperactivity (SMD = -0.03; CI 95%: -0.43, 0.36), irritability (SMD = -0.18; CI 95%: -0.51, 0.15), stereotypy (SMD = -0.03; CI 95%: -0.43, 0.36), inappropriate speech (SMD = -0.68; CI 95%: -1.49, 0.14), lethargy (SMD = -0.22; CI 95%: -0.58, 0.14), and social function (SMD = -0.71; IC 95%: -1.56, 0.14). W-3 and w-6 supplementation also showed no efficacy according to the Social Responsiveness Scale (SMD = 0.08; CI 95%: -0.23, 0.39). The adverse effects were classified as mild and equally distributed between the placebo and intervention groups. CONCLUSIONS: Despite w-3 and w-6 supplementation showing minimal beneficial effects in the treatment of autism, the subgroup analyses indicated that there is a lack of evidence on the beneficial role of w-3 and w-6 in treating ASD.Systematic Review Registration: PROSPERO number CRD42020146116.


Subject(s)
Autism Spectrum Disorder , Autistic Disorder , Fatty Acids, Omega-3 , Stereotypic Movement Disorder , Adolescent , Autism Spectrum Disorder/chemically induced , Autism Spectrum Disorder/drug therapy , Child , Dietary Supplements , Humans
3.
J Autism Dev Disord ; 50(8): 2987-3004, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32056114

ABSTRACT

Self-injurious behavior (SIB) occurs in up to 50% of individuals with autism. As one of the most serious conditions in individuals with developmental disabilities, SIB affects the individual and his or her family in multiple contexts. A systematic analysis of factors most commonly associated with SIB could inform the development of individualized intervention strategies. The current study examined factors related to SIB in an analysis of client records of 145 children with autism in a comprehensive care center. Predictor variables included age, gender, the Adaptive Behavior Composite, sensory processing, aggression, stereotypies, irritability, adaptive skills, and medical conditions. Age, irritability, and the Adaptive Behavior Composite were found to significantly predict SIB.


Subject(s)
Autism Spectrum Disorder/complications , Self-Injurious Behavior/etiology , Adolescent , Aggression , Autistic Disorder/complications , Child , Female , Humans , Irritable Mood , Male , Residential Treatment , Stereotypic Movement Disorder
4.
Toxicon ; 138: 59-67, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28811247

ABSTRACT

Bites of tiger spiders belonging to Poecilotheria genus cause moderate to severe pain and long-lasting local or generalized muscle cramps in humans. Bites occur in regions of the spiders' natural habitat, India and Sri Lanka, but the popularity of these colorful tarantulas as pets leads to reports of envenomation cases worldwide. Treatment is predominantly symptomatic and often inadequate since there is almost no clinical or toxicology research data available, and physicians outside India or Sri Lanka typically have no experience in treating such cases. We report toxicity studies of venom from nine Poecilotheria species in laboratory mice (Mus musculus Balb/C males). LD50 values are 5-14 mg of lyophilized crude venom per 1 kg (i.v.). The major symptoms of envenomation include tonic-clonic seizures, jerks, characteristic motor stereotypy, and hyperalgesia and point to voltage-gated sodium channels as a potential target of the venom components. Poecilotheria fasciata venom effects were studied in detail at a sub-lethal dose of 5 mg/kg (LD50 = 12 mg/kg). 13 widely used pharmacological agents (atropine, chloropyramine, chlorpromazine, diazepam, ethanol, flupirtine, haloperidol, ketotifen, lamotrigine, oxcarbazepine, tolperisone, xylazine, and CaCl2) were checked for ability to suppress the envenomation symptoms. Chlorpromazine (10 mg/kg, i.p.), oxcarbazepine (60 mg/kg, p.o.), tolperisone (50 mg/kg, s.c.) and xylazine (2.5 mg/kg, i.p.) were found effective as a pretreatment to mitigate muscle cramps and motor stereotypy. When administered after envenomation chlorpromazine (5 mg/kg, i.v.) effectively reduced the cramps, while oxcarbazepine (30 mg/kg, i.v.) and xylazine (1 mg/kg, i.v.) suppressed the stereotypy.


Subject(s)
Muscle Cramp/drug therapy , Spider Bites/drug therapy , Spider Venoms/toxicity , Stereotypic Movement Disorder/drug therapy , Animals , Chlorpromazine/pharmacology , Hyperalgesia , Male , Mice, Inbred BALB C , Oxcarbazepine/pharmacology , Seizures , Voltage-Gated Sodium Channels , Xylazine/pharmacology
5.
Behav Brain Res ; 331: 25-29, 2017 07 28.
Article in English | MEDLINE | ID: mdl-28526515

ABSTRACT

Previous investigations by our group have shown that prenatal exposure to lipopolysaccharide (LPS), which mimics infection by gram-negative bacteria, induces social, cognitive, and communication deficits. For a complete screening of autistic-like behaviors, the objective of this study was to evaluate if our rat model also induces restricted and repetitive stereotyped behaviors. Thus, we studied the self-grooming microstructure. We also studied the neurochemistry of hypothalamus and frontal cortex, which are brain areas related to autism to better understand central mechanisms involved in our model. Prenatal LPS exposure on gestational day 9.5 increased the head washing episodes (frequency and time), as well as the total self-grooming. However, body grooming, paw/leg licking, tail/genital grooming, and circling behavior/tail chasing did not vary significantly among the groups. Moreover, prenatal LPS induced dopaminergic hypoactivity (HVA metabolite and turnover) in the hypothalamus. Therefore, our rat model induced restricted and repetitive stereotyped behaviors and the other main symptoms of autism experimentally studied in rodent models and also found in patients. The hypothalamic dopaminergic impairments seem to be associated with the autistic-like behaviors.


Subject(s)
Behavior, Animal/drug effects , Grooming/drug effects , Hypothalamus/drug effects , Lipopolysaccharides/pharmacology , Animals , Autistic Disorder/psychology , Disease Models, Animal , Female , Hypothalamus/metabolism , Pregnancy , Prenatal Exposure Delayed Effects , Rats, Wistar , Social Behavior , Stereotypic Movement Disorder/drug therapy , Stereotypic Movement Disorder/psychology
6.
Nutr Neurosci ; 19(8): 346-351, 2016 Oct.
Article in English | MEDLINE | ID: mdl-25876214

ABSTRACT

OBJECTIVES: Autism spectrum disorder (ASD) is a developmental disorder characterized by pervasive deficits in social interaction, impairment in verbal and non-verbal communication, and stereotyped patterns of interests and activities. Vitamin-D deficiency was previously reported in autistic children. However, the data on the relationship between vitamin D deficiency and the severity of autism are limited. METHODS: We performed a case-controlled cross-sectional analysis conducted on 122 ASD children, to assess their vitamin D status compared to controls and the relationship between vitamin D deficiency and the severity of autism. We also conducted an open trial of vitamin D supplementation in ASD children. RESULTS: Fifty-seven percent of the patients in the present study had vitamin D deficiency, and 30% had vitamin D insufficiency. The mean 25-OHD levels in patients with severe autism were significantly lower than those in patients with mild/moderate autism. Serum 25-OHD levels had significant negative correlations with Childhood Autism Rating Scale (CARS) scores. Of the ASD group, 106 patients with low-serum 25-OHD levels (<30 ng/ml) participated in the open label trial. They received vitamin D3 (300 IU/kg/day not to exceed 5000 IU/day) for 3 months. Eighty-three subjects completed 3 months of daily vitamin D treatment. Collectively, 80.72% (67/83) of subjects who received vitamin D3 treatment had significantly improved outcome, which was mainly in the sections of the CARS and aberrant behavior checklist subscales that measure behavior, stereotypy, eye contact, and attention span. CONCLUSION: Vitamin D is inexpensive, readily available and safe. It may have beneficial effects in ASD subjects, especially when the final serum level is more than 40 ng/ml. TRIAL REGISTRATION NUMBER: UMIN-CTR Study Design: trial Number: R000016846.


Subject(s)
Autism Spectrum Disorder/diet therapy , Child Nutritional Physiological Phenomena , Cholecalciferol/therapeutic use , Dietary Supplements , Nutritional Status , Vitamin D Deficiency/diet therapy , Attention , Autism Spectrum Disorder/blood , Autism Spectrum Disorder/complications , Autism Spectrum Disorder/physiopathology , Calcifediol/blood , Case-Control Studies , Child , Child, Preschool , Cholecalciferol/metabolism , Cross-Sectional Studies , Egypt/epidemiology , Eye Movements , Humans , Hyperkinesis/etiology , Hyperkinesis/prevention & control , Male , Patient Compliance , Psychiatric Status Rating Scales , Severity of Illness Index , Social Behavior , Stereotypic Movement Disorder/etiology , Stereotypic Movement Disorder/prevention & control , Vitamin D Deficiency/blood , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiology
8.
Dev Med Child Neurol ; 56(12): 1212-1218, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24947872

ABSTRACT

AIM: The aim of this article is to describe a subgroup of children who presented with stereotyped movements in the context of episodes of intense imagery. This is of relevance to current discussions regarding the clinical usefulness of diagnosing motor stereotypies during development. METHOD: The sample consisted of 10 children (nine males, one female; mean age 8y 6mo [SD 2y 5mo], range 6-15y). Referrals were from acute paediatricians, neurologists, and tertiary epilepsy services. Children were assessed by multidisciplinary teams with expertise in paediatric movement disorders. RESULTS: Stereotypies presented as paroxysmal complex movements involving upper and lower limbs. Imagery themes typically included computer games (60%), cartoons/films (40%), and fantasy scenes (30%). Comorbid developmental difficulties were reported for 80% of children. Brain imaging and electrophysiological investigations had been conducted for 50% of the children before referral to the clinic. INTERPRETATION: The descriptive term 'intense imagery movements' (IIM) was applied if (after interview) the children reported engaging in acts of imagery while performing stereotyped movements. We believe these children may form a common and discrete stereotypy subgroup, with the concept of IIM being clinically useful to ensure the accurate diagnosis and clinical management of this paediatric movement disorder.


Subject(s)
Imagery, Psychotherapy/methods , Movement/physiology , Stereotypic Movement Disorder/diagnosis , Stereotypic Movement Disorder/physiopathology , Adolescent , Child , Female , Humans , Male , Stereotyped Behavior
9.
Curr Neurol Neurosci Rep ; 13(4): 341, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23423537

ABSTRACT

Agrypnia (from the Greek: to chase sleep) excitata (AE) is a syndrome characterized by loss of sleep and permanent motor and autonomic hyperactivation (excitata). Disruption of the sleep-wake rhythm consists in the disappearance of spindle-delta activities, and the persistence of stage 1 non-rapid eye movement (NREM) sleep. Rapid eye movement (REM) sleep persists but fails to stabilize, appearing in short recurrent episodes, isolated, or mixed with stage 1 NREM sleep. Diurnal and nocturnal motor, autonomic and hormonal overactivity is the second hallmark of AE. Of particular interest is the finding that norepinephrine secretion is extremely elevated at all hours of the day and night whereas the nocturnal melatonin peak is lacking. Oneiric stupor is probably an exclusive sign of AE and consists in the recurrence of stereotyped gestures mimicking simple daily life activities. Agrypnia excitata aptly defines 3 different clinical conditions, fatal familial insomnia (FFI), an autosomal dominant prion disease, Morvan syndrome (MS), an autoimmune encephalitis, and delirium tremens (DT), the alcohol withdrawal syndrome. Agrypnia excitata is due to an intralimbic disconnection releasing the hypothalamus and brainstem reticular formation from cortico-limbic inhibitory control. This pathogenetic mechanism is visceral thalamus degeneration in FI, whereas it may depend on autoantibodies blocking voltage-gated potassium (VGK) channels within the limbic system in MS, and in the sudden changes in gabaergic synapses down-regulated by chronic alcohol abuse within the limbic system in DT.


Subject(s)
Alcohol Withdrawal Delirium/complications , Insomnia, Fatal Familial/complications , Myokymia/complications , Psychomotor Agitation/etiology , Sleep Initiation and Maintenance Disorders/etiology , Alcohol Withdrawal Delirium/physiopathology , Animals , Atrophy , Autoantibodies/immunology , Autoantigens/immunology , Disease Models, Animal , Humans , Hypothalamus/physiopathology , Insomnia, Fatal Familial/diagnosis , Insomnia, Fatal Familial/physiopathology , Limbic System/physiopathology , Melatonin/deficiency , Mice , Myokymia/immunology , Myokymia/physiopathology , Norepinephrine/metabolism , Polysomnography , Potassium Channels, Voltage-Gated/immunology , Psychomotor Agitation/physiopathology , Reticular Formation/physiopathology , Sleep Initiation and Maintenance Disorders/physiopathology , Sleep Stages/physiology , Stereotypic Movement Disorder/etiology , Tachycardia/etiology , Thalamic Nuclei/pathology , Thalamic Nuclei/physiopathology
10.
Behav Modif ; 37(4): 543-67, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23144173

ABSTRACT

The authors evaluated the effects of matched and unmatched stimuli on immediate and subsequent engagement in targeted vocal stereotypy (Experiment 1) and untargeted motor stereotypy (Experiment 2). Results of Experiment 1 showed that (a) matched stimulation decreased immediate engagement in vocal stereotypy for 8 of 11 participants and increased subsequent engagement in vocal stereotypy for only 1 of the 8 participants and (b) unmatched stimulation decreased immediate engagement in vocal stereotypy for only 1 of 10 participants and did not increase subsequent engagement in vocal stereotypy for this participant. Results of Experiment 2 showed that for 8 of 14 participants, untargeted stereotypy increased when the matched or unmatched stimulus was present, after it was removed, or both. The authors briefly discuss the potential clinical implications of using matched stimulation to decrease vocal stereotypy and limitations of the findings.


Subject(s)
Acoustic Stimulation , Behavior Therapy , Photic Stimulation , Stereotyped Behavior , Stereotypic Movement Disorder/therapy , Verbal Behavior , Adolescent , Child , Female , Humans , Male
11.
Clin Toxicol (Phila) ; 51(1): 16-22, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23194021

ABSTRACT

INTRODUCTION: Crude extracts of Boophone disticha are used in Southern African traditional medical practice for the management of various illnesses and conditions and have also been abused for their claimed euphoric and hallucinogenic effects. Unfortunately, ingestion of Boophone disticha has resulted in toxicity and death. The results of a recent acute toxicity study in a rat model insinuated that central nervous system (CNS) serotonin overdrive could be the cause of toxicity in B. disticha poisoning. The present work sought to test that hypothesis by investigating whether pre-treatment of B. disticha poisoned BALB/c mice with the CNS acting serotonin antagonist, cyproheptadine, has a dose-dependent protective effect on toxicity and mortality. METHODS: A hydroethanolic extract of B. disticha was used in all the experiments. Five groups each with 10 animals were constituted as follows; a negative control group (received 10 ml/kg Normal Saline), a positive control group (received 375 mg/kg of the B. disticha extract), and three test groups each receiving 10 mg/kg, 15 mg/kg and 20 mg/kg cyproheptadine intraperitoneally 15 minutes before oral gavage administration of 375 mg/kg B. disticha extract respectively. The Functional Observational Battery was used to evaluate neurobehavioral and physiological changes resulting from toxicity of the plant extract. The mice were then placed in an open field for another five minutes and the number of rearings and border crossings were counted and recorded. Gait abnormalities, involuntary motor movements, mobility, arousal and stereotypical behavior were also scored according to predefined criteria. All open field investigations were recorded electronically using a LABTEC Webcam(®) and results were later analysed and recorded by one of the group members. All results were entered on data collection forms. Time to death (survival time) was considered as the time period from dosage with Boophone disticha to time of death. The study follow up period was 7 days and those mice that were alive at the end of the 7 day follow-up period were considered as having survived the poisoning episode. The Kaplan Meier plot and Log-rank test were used to compare differences in mortality and median time to death for mice in the 5 treatment groups. RESULTS: We found that cyproheptadine pre-treatment led to a dose-dependent decrease in mortality from 80% in the group not pre-treated with cyproheptadine, to 30% in the 15 and 20 mg/kg cyproheptadine pre-treated groups (n = 10 per group, p < 0.05). There was also a dose-dependent increase in median survival times amongst the groups (p < 0.0001). Pre-treatment with cyproheptadine also resulted in a decrease of other toxic symptoms associated with Boophone disticha. CONCLUSIONS: We conclude that cyproheptadine has a dose-dependent protective effect on mortality and toxicity produced by exposure to Boophone disticha in our mouse model of toxicity.


Subject(s)
Cyproheptadine/therapeutic use , Embryophyta/chemistry , Hallucinogens/antagonists & inhibitors , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/prevention & control , Plant Extracts/antagonists & inhibitors , Serotonin Antagonists/therapeutic use , Africa, Southern , Animals , Behavior, Animal/drug effects , Cyproheptadine/administration & dosage , Dose-Response Relationship, Drug , Embryophyta/growth & development , Female , Gait Disorders, Neurologic/etiology , Gait Disorders, Neurologic/prevention & control , Hallucinogens/poisoning , Male , Medicine, African Traditional , Mice , Mice, Inbred BALB C , Neuroprotective Agents/administration & dosage , Neurotoxicity Syndromes/physiopathology , Plant Extracts/poisoning , Plant Roots/chemistry , Plant Roots/growth & development , Serotonin Antagonists/administration & dosage , Stereotypic Movement Disorder/etiology , Stereotypic Movement Disorder/prevention & control , Survival Analysis , Zimbabwe
12.
Rev. neurol. (Ed. impr.) ; 54(supl.5): s61-s68, 3 oct., 2012. tab
Article in Spanish | IBECS | ID: ibc-150366

ABSTRACT

Se observa un interés creciente por el estudio de los síntomas extranígricos de la enfermedad de Parkinson, como las alteraciones de la marcha, que conllevan una importante disminución de la calidad de vida. La marcha es un proceso complejo cuya afectación puede explicarse por la suma de elementos como hipocinesia, asimetría en el movimiento de ambos hemicuerpos, disfunción ejecutiva, alteraciones en la sensibilidad propioceptiva, factores ambientales y emocionales. En la regulación de la marcha y la postura están implicadas diversas estructuras cerebrales y neurotransmisores que en la enfermedad de Parkinson tienen alterada su activación. En las fases iniciales los trastornos de la marcha son controlados aceptablemente con fármacos dopaminérgicos pero la respuesta a estos medicamentos no es satisfactoria en fases avanzadas, lo cual ha llevado a investigar sustancias con otros mecanismos de acción (metilfenidato, dihidroxifenilserina, anticolinesterásicos, memantina, inhibidores selectivos de los receptores de serotonina, entre otros) y tratamientos no farmacológicos como cirugía (estimulación cerebral profunda del núcleo subtalámico y del pedunculopontino), fisioterapia y acupuntura (AU)


There is currently a growing interest in the study of the extra-nigral symptoms of Parkinson's disease, such as gait disorders, which result in an important reduction in quality of life. Walking is a complex process and the problems affecting it can be explained by the sum of elements like hypokinesia, asymmetry in the movement of the two halves of the body, executive dysfunction, alterations affecting proprioceptive sensitivity, and environmental and emotional factors. The activation of a number of different brain structures and neurotransmitters involved in the regulation of gait and posture is altered in Parkinson's disease. In the early phases gait disorders are controlled to an acceptable extent with dopaminergic drugs, but the response to these agents is not satisfactory in advanced phases. This has led researchers to look for substances with other mechanisms of action (methylphenidate, dihydroxyphenylserine, anticholinesterases, memantine and selective serotonin receptor inhibitors, among others) and non-pharmacological treatments such as surgery (deep brain stimulation of the subthalamic nucleus and of the pedunculopontine), physiotherapy and acupuncture (AU)


Subject(s)
Humans , Male , Female , Parkinson Disease/genetics , Stereotypic Movement Disorder/physiopathology , Quality of Life/psychology , Hypokinesia/metabolism , Acupuncture Therapy/classification , Dopamine Agonists/administration & dosage , Epilepsy, Absence/diagnosis , Disorders of Excessive Somnolence/physiopathology , Parkinson Disease/pathology , Stereotypic Movement Disorder/metabolism , Quality of Life , Hypokinesia/physiopathology , Acupuncture Therapy/methods , Dopamine Agonists/supply & distribution , Epilepsy, Absence/complications , Disorders of Excessive Somnolence/diagnosis
13.
Res Dev Disabil ; 33(4): 1183-93, 2012.
Article in English | MEDLINE | ID: mdl-22502844

ABSTRACT

The effects of 14 weeks of Kata techniques training on stereotypic behaviors of children with autism spectrum disorders (ASD) were investigated. The study included 30 eligible (diagnosed ASD, school age) children with ages ranging from 5 to 16 years whom they assigned to an exercise (n=15) or a no-exercise control group (n=15). Participants of the exercise group received Kata techniques instruction four times per week for 14 weeks (56 sessions). Stereotypy was assessed at baseline (pre-intervention), week 14 (post-intervention), and at one month follow up in both groups. Results showed that Kata techniques training significantly reduced stereotypy in the exercise group. Following participation in Kata techniques training, stereotypy decreased from baseline levels by a M of 42.54% across participants. Interestingly, after 30 days of no practice, stereotypy in the exercise group remained significantly decreased compared to pre-intervention time. The participants of the control group did not show significant changes in the stereotypy. Teaching martial arts techniques to children with ASD for a long period of time consistently decreased their stereotypic behaviors.


Subject(s)
Child Development Disorders, Pervasive/rehabilitation , Complementary Therapies/methods , Martial Arts , Stereotyped Behavior , Stereotypic Movement Disorder/rehabilitation , Adolescent , Child , Child Development Disorders, Pervasive/complications , Child Development Disorders, Pervasive/physiopathology , Child, Preschool , Exercise Therapy/methods , Female , Humans , Male , Stereotypic Movement Disorder/etiology , Stereotypic Movement Disorder/physiopathology , Treatment Outcome
14.
J Appl Behav Anal ; 45(1): 185-90, 2012.
Article in English | MEDLINE | ID: mdl-22403464

ABSTRACT

We evaluated the effects of 3 types of noncontingent auditory stimulation (music, white noise, recordings of vocal stereotypy) on 2 children with autism who engaged in high rates of vocal stereotypy. For both participants, the music condition was the most effective in decreasing vocal stereotypy to near-zero levels, resulted in the highest parent social validity ratings, and was selected as most preferred in treatment preference evaluations.


Subject(s)
Acoustic Stimulation/methods , Auditory Perception , Autistic Disorder/complications , Stereotypic Movement Disorder/etiology , Stereotypic Movement Disorder/rehabilitation , Voice , Child , Female , Humans , Music Therapy/methods , Reproducibility of Results , Social Behavior , Stereotyped Behavior/physiology , Time Factors , Treatment Outcome
15.
Span. j. psychol ; 14(2): 899-911, nov. 2011. tab, ilus
Article in English | IBECS | ID: ibc-91230

ABSTRACT

This study was designed to develop a computerized test to assess gender roles. This test is presented as a decision-making task to mask its purpose. Each item displays a picture representing an activity and a brief sentence that describes it. Participants have to choose the most suitable sex to perform each activity: man or woman. The test (Gender Roles Test, GRT-36) consists of 36 items/activities. The program registers both the choices made and their response times (RTs). Responses are considered as stereotyped when the chosen sex fits stereotyped roles and non-stereotyped when the chosen sex does not fit stereotyped roles. Individual means (RTs) were computed for stereotyped and non-stereotyped responses, differentiating between domestic and work spheres. A «D» score, reflecting the strength of association between activities and sex, was calculated for each sphere and sex. The study incorporated 78 participants (69% women and 31% men) ranging from 19 to 59 years old. The results show that: (a) reading speed does not explain the variability in the RTs; (b) RTs show good internal consistency; (c) RTs are shorter for stereotyped than for neutral stimuli; (d) RTs are shorter for stereotyped than for non-stereotyped responses. Intended goals are supported by obtained results. Scores provided by the task facilitate both group and individual detailed analysis of gender role, differentiating the gender role assigned to men from that assigned to women, at the domestic and work spheres. Obtained data fall within the scope of the genderology and their implications are discussed (AU)


El objetivo del estudio ha sido elaborar un test informatizado, para valorar los roles de género, presentado como tarea de toma de decisiones para enmascarar su objetivo. En cada ítem hay que elegir entre varones o mujeres, según se los/as considere más idóneos para realizar cada actividad. La prueba consta de 36 ítems/actividades. El programa registra tanto la elección como el tiempo de respuesta (TR). Las respuestas se clasifican en estereotipadas (concordancia sexo y rol estereotipado) y no estereotipadas (discordancia sexo y rol estereotipado). Para cada uno de estos grupos se calcula el TR medio, diferenciando ámbito doméstico y laboral. También se calcula una puntuación de fuerza de asociación de la respuesta (D) para cada ámbito y sexo. En el estudio participaron 78 personas (69% mujeres y 31% varones) entre 19 y 59 años. Los resultados manifiestan que: (a) la velocidad de lectura no explica la variabilidad en los TR; (b) los TR muestran buena consistencia interna; (c) los TR son más breves ante estímulos estereotipados que neutros; (d) los TR son más breves para las respuestas estereotipadas que para las no estereotipadas. Los resultados avalan el ajuste del test a los objetivos establecidos. Las puntuaciones facilitan tanto el análisis del rol de género en grupos como el perfil individual, diferenciando el rol de género adscrito a la mujer del adscrito al varón, tanto en el ámbito doméstico como en el laboral. Estos resultados se enmarcan dentro del ámbito de la generología y se discuten sus implicaciones (AU)


Subject(s)
Humans , Male , Female , Young Adult , Adult , Middle Aged , Gender Identity , Role , Role Playing , Sex Ratio , Masculinity , Femininity , Stereotypic Movement Disorder/psychology
16.
Einstein (Säo Paulo) ; 9(3)july-sept. 2011. tab, graf
Article in English, Portuguese | LILACS | ID: lil-604951

ABSTRACT

Objective: To evaluate the functional mobility of patients with stroke over 12 sessions of hydrotherapy. Methods: Ten stroke patients aged between 5 and 85 years were evaluated by means of the Timed Up and Go test, which contains some items, such as balance, walking speed, changing directions, and standing up from a seated position. The study patients performed the test before and after each hydrotherapy session (total of 12 sessions). Each individual was compared to him/herself both short-term (pre- and post-therapy) and long-term (after 12 therapy sessions). Result: Comparing baseline and after 12 sessions, it was noted that the 10 patients improved their performance, with a decrease in time to execute the Timed Up and Go test. Conclusion: An exercise program in a hydrotherapy pool was beneficial for functional mobility performance improvement in stroke patients.


Objetivo: Avaliar a mobilidade funcional de pacientes com acidente vascular cerebral no decorrer de 12 sessões de hidroterapia. Métodos: Foram avaliados 10 pacientes com acidente vascular cerebral com idades entre 5 e 85 anos por meio do teste Timed Up and Go, que contém itens como equilíbrio, velocidade da marcha, mudança de direção e transferência de sentado para em pé. Os pacientes do estudo realizaram o teste antes e depois de cada sessão de hidroterapia (total de 12 terapias). Cada indivíduo foi comparado com ele mesmo, a curto prazo (pré e pós-terapia) e a longo prazo (após 12 terapias). Resultado: Comparados no início e ao final das 12 sessões, verificou-se que os 10 pacientes melhoraram sua performance, apresentando diminuição do tempo na execução do teste Timed Up and Go. Conclusão: O programa de exercícios em piscina terapêutica foi benéfico para melhora da performance da mobilidade funcional de pacientes portadores de acidente vascular cerebral.


Subject(s)
Stroke/rehabilitation , Gait , Hydrotherapy , Physical Therapy Modalities , Postural Balance , Stereotypic Movement Disorder
17.
Behav Modif ; 34(4): 267-89, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20562321

ABSTRACT

The purpose of this study was to reduce stereotypy and challenging behavior during play skills instruction by adding an abolishing operation component (AOC) to the intervention strategy. An alternating treatments design compared one condition in which participants were allowed to engage in stereotypy freely before beginning the play skills intervention (AOC condition) to a second condition without this free access period (No AOC condition). Across 4 participants with autism spectrum disorders (ASD), levels of stereotypy and challenging behavior were lower and functional play was higher during play intervention sessions that followed the AOC. These data provided support for the inclusion of an AOC in interventions aimed at increasing the play skills of children with ASD who present with stereotypy.


Subject(s)
Child Development Disorders, Pervasive/therapy , Play Therapy/methods , Stereotypic Movement Disorder/therapy , Child , Child Development Disorders, Pervasive/complications , Child, Preschool , Female , Humans , Male , Reinforcement, Psychology , Satiation , Stereotypic Movement Disorder/complications
18.
J Altern Complement Med ; 14(8): 1057-65, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18990052

ABSTRACT

OBJECTIVE: The objective of this study was to observe for efficacy, safety, and compliance of electroacupuncture for autism spectrum disorder (ASD). METHODS: Two (2) children with ASD received electroacupuncture for 24 sessions over 8 weeks and were assessed pre- and postacupuncture. We defined a positive or negative change as an improvement or deterioration of 25%, respectively, in total score or any subscales of Aberrant Behavioral Checklist (ABC), Ritvo-Freeman Real Life Scale (RFRLS), WeeFIM, and as a rating of much improved or much worse on the Clinical Global Impression-Improvement (CGI-I) scale. RESULTS: For ABC, positive changes in "Irritability" and "Stereotypy" was noted in case 1 but no changes occurred for case 2. For RFRLS, positive changes were found for both cases in "Sensory motor," "Sensory response," and "Total score," although negative change was noted for case 2 in "Affectual response." For WeeFIM, there were no positive or negative changes in both cases. For CGI-I, positive change in case 1 with much improved in "Social relatedness, Communication, and Stereotypy behavior" was reported. CONCLUSIONS: A short intensive course of electroacupuncture might improve some core features of children with ASD.


Subject(s)
Autistic Disorder/therapy , Child Behavior Disorders/therapy , Child Behavior , Electroacupuncture/methods , Stereotypic Movement Disorder/therapy , Autistic Disorder/complications , Child , Child Behavior/psychology , Child Behavior Disorders/etiology , Female , Humans , Male , Stereotypic Movement Disorder/etiology , Treatment Outcome
19.
East Afr Med J ; 84(5): 219-25, 2007 May.
Article in English | MEDLINE | ID: mdl-17892196

ABSTRACT

BACKGROUND: Khat is a plant whose young shoots and leaves are habitually used in Eastern Africa and the Arabian Peninsula as a drug of recreation. Although it is used without any control in these regions, it contains two controlled substances, cathinone (schedule I) which is present in fresh khat and cathine (schedule VI) which is a degradation product of cathinone abundant in old khat. OBJECTIVE: To determine the effect of khat on locomotor behaviour and seizures in rats. DESIGN: Experimental study. SETTING: University of Nairobi. SUBJECTS: Adult male rats in groups of six were given fresh khat, old khat, methylphenidate and saline at varying doses and observed over three hours. RESULTS: Fresh khat at low doses and old khat at high doses stimulated locomotor activity. High doses of fresh and old khat induced stereotype behaviour and seizures. CONCLUSION: The results show that khat stimulates locomotor and stereotypic behavioural activity and can induce seizures; results similar to those observed with amphetamine analogs.


Subject(s)
Catha/toxicity , Motor Activity/drug effects , Seizures/chemically induced , Stereotypic Movement Disorder/chemically induced , Alkaloids/toxicity , Analysis of Variance , Animals , Behavior, Animal/drug effects , Dose-Response Relationship, Drug , Kenya , Male , Methylphenidate/administration & dosage , Methylphenidate/pharmacokinetics , Observation , Phenylpropanolamine/toxicity , Plant Preparations/toxicity , Rats , Rats, Sprague-Dawley , Time Factors
20.
Toxicol Appl Pharmacol ; 208(3): 266-76, 2005 Nov 01.
Article in English | MEDLINE | ID: mdl-16239169

ABSTRACT

Two tests, a functional observational battery (FOB) and measurement of motor activity, have been used to screen the two NHE inhibitors EMD 96785 and EMD 125021 for neurobehavioral effects. These two NHE inhibitors, which exhibit a marked selectivity for the NHE 1 isoform, are under development in the research laboratories of Merck KGaA. NHE inhibitors are developed for the treatment of acute myocardial infarction and chronic heart failure. In prior studies with EMD 96785 and EMD 125021, clinical symptoms, such as uncoordinated movements and weakness of the hindlimbs, were detected in rats. The aim of this study was the evaluation of clinical findings in more detail using a FOB and measurement of motor activity in 96 female rats. The time course and reversibility of the adverse effects were investigated. The animals were treated with EMD 96785 or EMD 125021 by intravenous injection at a single dose of 100 mg/kg and four different time points (2 h, 1 day, 7 days and 21 days after treatment) were chosen for the clinical examination. This neurobehavioral test battery clearly detected neurological activity and defined time-course characteristics after treatment with EMD 96785 or EMD 125021. The various clinical parameters were grouped into functional-related domains and most alterations were seen in the domains of central nervous system and neuromuscular system. The most prominent clinical findings were seen with the pharmacologically more potent NHE inhibitor EMD 125021 when compared to EMD 96785. The clinical symptoms were proven to be reversible by 7 days after the single treatment for both compounds.


Subject(s)
Behavior, Animal/drug effects , Motor Activity/drug effects , Sodium-Hydrogen Exchangers/antagonists & inhibitors , Animals , Ataxia/chemically induced , Behavior, Animal/physiology , Body Temperature/drug effects , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical/methods , Female , Gait/drug effects , Guanidines/administration & dosage , Guanidines/pharmacokinetics , Hand Strength , Hindlimb/drug effects , Injections, Intravenous , Motor Activity/physiology , Posture , Rats , Rats, Wistar , Reflex, Pupillary/drug effects , Reflex, Pupillary/physiology , Sodium-Hydrogen Exchanger 1 , Sodium-Hydrogen Exchangers/administration & dosage , Sodium-Hydrogen Exchangers/pharmacokinetics , Stereotypic Movement Disorder/chemically induced , Sulfones/administration & dosage , Sulfones/pharmacokinetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL